Cardiovascular Systems Inc. (NASDAQ: CSII)

Engel Law PLLC is investigating whether fair value to Cardiovascular Systems shareholders will result from the proposed sale of Cardiovascular Systems Inc. (NASDAQ: CSII) to Abbott for $20 per common share.

The Firm’s investigation concerns:

(i) whether the Company’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction;
(ii) whether the merger consideration adequately compensates the Company’s shareholders; and
(iii) whether all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.

Join this Action

Cardiovascular Systems Inc.

MM slash DD slash YYYY